These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10673284)

  • 41. The importance of screening for hemochromatosis.
    Dubois S; Kowdley KV
    Arch Intern Med; 2003 Nov; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract]   [Full Text] [Related]  

  • 42. Haemochromatosis.
    Pietrangelo A
    Gut; 2003 May; 52 Suppl 2(Suppl 2):ii23-30. PubMed ID: 12651879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of genotypic and phenotypic strategies for population screening in hemochromatosis: assessment of anxiety, depression, and perception of health.
    Patch C; Roderick P; Rosenberg W
    Genet Med; 2005 Oct; 7(8):550-6. PubMed ID: 16247293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.
    McCune CA; Ravine D; Carter K; Jackson HA; Hutton D; Hedderich J; Krawczak M; Worwood M
    Gut; 2006 Apr; 55(4):554-62. PubMed ID: 16174659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing families with HFE-related hereditary haemochromatosis.
    Siezenga MA; Rasp E; Wijermans PW
    Neth J Med; 2004 May; 62(5):156-9. PubMed ID: 15366698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The prioritisation of genetic screening with primary haemochromatosis as an example].
    de Craen AJ; van Aken MO; Westendorp RG
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1442-5. PubMed ID: 12908344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid detection of genetic mutations associated with haemochromatosis.
    Guttridge MG; Thompson J; Worwood M; Darke C
    Vox Sang; 1998; 75(3):253-6. PubMed ID: 9852416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemochromatosis case detection by genetic testing: a new era.
    Kilpatrick ES; Jagger C
    Ann Clin Biochem; 1998 Sep; 35 ( Pt 5)():674-7. PubMed ID: 9768336
    [No Abstract]   [Full Text] [Related]  

  • 50. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama.
    Barton JC; Acton RT
    Genet Test; 2000; 4(2):199-206. PubMed ID: 10953960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemochromatosis: the importance of mutation screening in the family].
    ter Braak N; Erdkamp FL; van Deursen CT
    Ned Tijdschr Geneeskd; 2009 Apr; 153(16):765-7. PubMed ID: 19469149
    [No Abstract]   [Full Text] [Related]  

  • 53. Lessons from a survey of genotyping for hereditary haemochromatosis.
    Francis S; Thachil J
    J Clin Pathol; 2015 Jul; 68(7):578. PubMed ID: 25935547
    [No Abstract]   [Full Text] [Related]  

  • 54. Haemochromatosis and the liver.
    Niederau C; Erhardt A; Häussinger D; Strohmeyer G
    J Hepatol; 1999; 30 Suppl 1():6-11. PubMed ID: 10370895
    [No Abstract]   [Full Text] [Related]  

  • 55. Hereditary haemochromatosis - diagnosis and management.
    Allen K
    Aust Fam Physician; 2010 Dec; 39(12):938-41. PubMed ID: 21301675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    J Med Genet; 2008 Aug; 45(8):513-8. PubMed ID: 18310265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.